The Distinguished Scientist Award seeks to provide career and research support to early career scientists who demonstrate outstanding promise for making scientific and medical breakthroughs in the field of brain cancer research.
Recipients of the award are inspired individuals with projects that show potential to generate new knowledge relating to causes, cure or treatment of primary brain tumors/brain cancer. Applicants are carefully considered and selected by The Sontag Foundation and its independent Scientific Advisory Board based on the scientific merit of the proposed project, career trajectory, peer and mentor references and an onsite research facility visit.
The award provides up to $600,000 in funding over a four-year period. Over that time, recipients also receive additional support from the Foundation through its vast network of scientists in the field and annual alumni conference.
Interested applicants should carefully read the following information about the award and application process before applying, as reapplications are not considered.
The application deadline for 2017 is March 15, 2017.
- The funding period for 2017 grants will begin on or about October 15, 2017 and end on September 30, 2021.
- The DSA award provides up to $600,000 spread over a four-year period. The total amount of the award is determined based on an approved budget request and is disbursed to the institution in quarterly payments.
- Progress reports must be received and approved prior to second, third and fourth year of funding.
- The Sontag Foundation will allow up to 15% of the award to support institutional overhead. Indirect costs are calculated based on the direct costs for a maximum annual payout of $150,000.
- Applicants must hold a doctoral degree in a discipline which can be brought to bear on the intractable disease, brain cancer.
- At the time of application, applicants must hold their first independent full-time faculty appointment at the level of assistant professor, independent researcher or equivalent position at a tax-exempt 501(c)(3) academic, research or medical institution within the United States or an equivalent institution in Canada, appointment must have been made no earlier than March 1, 2014.
- If the institution grants tenure, the qualifying appointment must be on the tenure track.
- Research proposal submitted for funding must be a primary focus of applicant.
- Applicant's career track and proposed research should demonstrate potential to generate new knowledge relating to causes, cure or treatment of primary brain tumors/brain cancer.
- More than one individual from the same institution may apply for this award.
- Reapplications in subsequent years of eligibility will be accepted by invitation only.
- Acknowledgment of support from The Sontag Foundation should be made when findings from sponsored research are reported.
- Should the recipient wish to discontinue or substantially change the proposed project, leave the current institution or otherwise modify any terms of the award, he or she must seek approval of The Sontag Foundation in advance.
- Four-year support is contingent upon continued evidence of satisfactory progress.
Forms to be used for the 2017 application cycle can be found on the official website.
For more information please click "Further Official Information" below.
This opportunity has expired. It was originally published here: